MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

MethylScan is a low-cost blood test that detects multiple cancers and liver diseases by analyzing DNA methylation patterns ...

To test the accuracy of MethylScan, researchers analyzed blood samples from 1,061 people, including patients with liver, lung ...

Scientists have developed a simple and cost-effective blood test that shows promise for detecting multiple cancers, various ...

UCLA scientists have developed a simple and cost-effective blood test that, in early studies, shows promise in detecting multiple cancers, various liver conditions and organ abnormalities ...

Researchers suggest their approach has the potential to transform early disease detection and health monitoring across diverse clinical settings.

Saqib Islam, chief executive Officer of newly launched Beeline Medicines. The pace of private financing in biopharma steps up ...

MethylScan is a new low-cost cell-free DNA methylome test that removes much of the healthy blood DNA background, helping rare ...

Roche has received CE mark approval of its Elecsys neurofilament light chain (NfL) test, which is designed to detect ...